{
    "title": "US FDA panel says Amgen lung cancer drug data cannot be relied on",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12599449/US-FDA-panel-gives-thumbs-approval-Amgen-lung-cancer-drug.html",
    "date": "2023-10-05",
    "keywords": [
        "drug",
        "approval",
        "fda",
        "study",
        "trial",
        "lung",
        "cancer",
        "confirmatory",
        "decision",
        "disease",
        "bhanvi",
        "satija",
        "pratik",
        "jain",
        "type",
        "goal",
        "expert",
        "chemotherapy",
        "lumakras",
        "gene",
        "food",
        "administration",
        "thursday",
        "agencys",
        "pathway",
        "condition",
        "pfs",
        "spokesperson",
        "agency",
        "move",
        "market",
        "singh",
        "oncology",
        "division",
        "fdas",
        "latestage",
        "panel",
        "question",
        "discussion",
        "treatment",
        "control",
        "risk",
        "progression",
        "difference",
        "survival",
        "standard",
        "amgen",
        "benefit",
        "line",
        "assessment",
        "staff",
        "week",
        "way",
        "loss",
        "consent",
        "need",
        "safety",
        "efficacy",
        "order",
        "form",
        "nonsmall",
        "cell",
        "advice",
        "dec",
        "reporting",
        "begaluru",
        "deena",
        "beasley",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}